SK, Novavax expand collaboration for Omicron-specific Covid-19 vaccine
The expanded collaboration requires SK bioscience to manufacture a version of Novavax’s Covid-19 vaccine that targets the Omicron…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jul 22
The expanded collaboration requires SK bioscience to manufacture a version of Novavax’s Covid-19 vaccine that targets the Omicron…
19 Jul 22
Enterome will receive a €40m upfront payment in cash and equity and is eligible to receive additional payments,…
15 Jul 22
Theravance will receive total consideration of more than $1.5bn, including around $1.1bn in an upfront payment, and up…
13 Jul 22
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
12 Jul 22
Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…
11 Jul 22
As per the agreement, the companies will develop and market Zynlonta for all hematologic and solid tumour indications,…
08 Jul 22
Emergent will manufacture, sell, and distribute Ebanga in the US and Canada, while Ridgeback will serve as the…
04 Jul 22
Under the new agreement, Oxford Biomedica will manufacture AstraZeneca’s Covid-19 vaccines at its 84,000ft² manufacturing facility in Oxbox,…
04 Jul 22
The company is entitled to receive a settlement fee of $55m and will assume responsibility for the marketing…
01 Jul 22
The financing from two life science-focused investors is expected to provide capital to expand Blueprint’s pipeline towards commercialisation…